Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial


John C Araujo,Géralyn C Trudel,Fred Saad,Andrew J Armstrong,Evan Y Yu,Joaquim Bellmunt,George Wilding,John McCaffrey,Sergio V Serrano,Vsevolod B Matveev,Eleni Efstathiou,Stephane Oudard,Michael J Morris,Bruce Sizer,Peter J Goebell,Axel Heidenreich, et al.


The Lancet Oncology




December 2013

Copyright © 2013, Elsevier

 User ID  
 Enable Auto Login
Forgot Password/User ID?
If you're a copyright.com user, you can login to RightsLink using your copyright.com credentials.
Already a RightsLink user or want to learn more?

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.

I would like to...


To request permission for a type of use not listed, please contact Elsevier Global Rights Department.

Are you the author of this Elsevier journal article?


Copyright © 2014 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com